Antiangiogenic Therapy Should be Considered Standard Treatment in the Adjuvant Therapy of Epithelial Ovarian Cancer
Crossref DOI link: https://doi.org/10.1007/s40944-017-0151-z
Published Online: 2017-12-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rajappa, Senthil J.
License valid from 2017-12-01